Symbol       Canada   US  

Company Profile



Fennec Pharmaceuticals Inc.
Symbol: TSX: FRX    
Address: 68 TW Alexander Drive, PO Box 13628
Research Triangle Park, North Carolina 27709, USA
Phone: (919) 636-4530
Fax: (919) 890-0490
Email: info@fennecpharma.com
Website: www.fennecpharma.com
Contact: Rosty Raykov, CEO
Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients. STS has received Orphan Drug Designation in the US in this setting.

People also search for:
Drug Development Stocks
Biotechnology Stocks
Pharmaceuticals Stocks
Financial Results
 Current Quarter
Jun 30 - 2Q
Year Ago Quarter
Jun 30 - 2Q
Revenue (000s) - -
Net Income (000s) (1,598) US$ (724) US$
EPS (0.11) US$ (0.06) US$
 Current 6 monthsYear Ago 6 months
Revenue (000s) - -
Net Income (000s) (2,404) US$ (1,144) US$
EPS (0.17) US$ (0.10) US$


Search by Symbol       Canada   US  


Top